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What is known 
about psychosis 
prevention
Psychotic disorders typically involve delusions and hallucinations, among other symptoms.1 Delusions are strongly held false beliefs that 
persist despite evidence to the contrary and that 
cannot be explained by the individual’s cultural or 
religious background. Hallucinations are sensations, 
such as hearing voices, in the absence of external 
causes. Psychosis may also include disorganized 
thinking, atypical motor behaviour and “negative” 
symptoms, such as loss of motivation and lack of 
social engagement. As with many mental disorders, 
potentially reversible causes such as infection or 
intoxication must be ruled out when diagnosing 
psychosis. Schizophrenia, schizoaffective disorder and 
delusional disorder are among the psychotic disorders 
recognized in the Diagnostic and Statistical Manual of 
Mental Disorders.1
When primary prevention is possible
Controversy persists about whether it is possible to prevent all forms of psychosis. But one form — namely 
substance-induced psychotic disorders — is clearly preventable. Youth can develop these disorders due to 
substance intoxication or withdrawal, including from alcohol and cannabis. And many young Canadians 
require medical care for this problem. In fact, among 10- to 24-year-olds, 15% of hospital stays for harms 
caused by substance use involved this form of psychosis, leading to 3,537 hospitalizations between 2017  
and 2018.2
Reducing the number of youth who experience substance-induced psychosis is a viable 
goal. Mainly, this can be achieved by providing effective substance use prevention programs 
and by offering effective treatments to youth who are struggling with problematic substance 
use. (Please see previous Quarterly issues for more information on primary and targeted 
prevention programs as well as effective treatments for problematic substance use.)
Determining who is at greatest risk
Researchers are now examining whether it is possible to prevent other psychotic disorders, beyond substance-
induced psychosis. The first step in developing prevention interventions for any health problem is usually 
to understand the underlying causes. However, understanding these causes can be challenging for disorders 
like schizophrenia that appear to arise from complex interactions when multiple environmental exposures 
influence gene expression over time. These interactions also play out across dynamic stages of brain 
development throughout childhood and adolescence, making it difficult to pinpoint targets for prevention 
Substance-induced psychotic disorders are preventable.
Controversy persists 
about whether it is 
possible to prevent all 
forms of psychosis.
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programming.3 Environmental factors, such as prenatal and perinatal exposures to infections and stress, 
may be the best candidates for prevention efforts. Yet even these environmental factors are not understood 
sufficiently to inform the development of interventions.3
In the interim, another approach involves identifying young people most at risk for psychosis, and then 
developing interventions to reduce their risk. To this end, consensus has emerged around using a precisely 
defined “clinical high-risk” threshold to identify those who are most likely to develop psychosis. To meet this 
threshold, youth must experience at least one of the following:
•	 subthreshold	psychotic	symptoms	such	as	intermittent,	brief	periods	of	disorganized	speech
•	 psychotic	symptoms	that	are	brief,	self-limiting	and	resolve	without	treatment	
•	 significantly	decreased	functioning	coupled	with	having	a	first-degree	relative	with	a psychotic disorder4
These clinical high-risk criteria are now widely used in research, including in the three intervention studies 
accepted for the Review article that follows.
Balancing benefits and harms of early identification
Considerable potential benefits come with correctly predicting who may be at high risk for psychosis. 
The most important benefit is that early identification may facilitate more youth receiving effective early 
interventions.5 Early identification and intervention in turn may lead to other benefits, such as better 
engagement with mental health services and with practitioners.5 Compounding these benefits, youth receiving 
early mental health services may be less likely to need hospital care for psychosis, compared with those who 
receive services only after psychosis develops.6
Yet the clinical high-risk criteria have also garnered criticism. A systematic review 
examining 27 studies on this topic found that most individuals who met the clinical high-
risk threshold did not go on to develop psychotic disorders.7 Specifically, 18% developed a 
psychotic disorder at six-month follow-up, 22% at one year, 29% at two years and 32% at 
three years.7 In other words, nearly two-thirds of those deemed high risk did not develop 
a psychotic disorder during the ensuing three years. Importantly, being older increased the 
risk of developing a psychotic disorder, suggesting that the designation may have less utility 
for youth. As well, being treated with antipsychotics reduced the risk of developing a psychotic disorder. 
Among those prescribed antipsychotics, 22.9% developed a psychotic disorder, compared with 36.5% of those 
who were not prescribed these medications.7
There is also considerable potential for harm in incorrectly labelling a young person as being at high 
risk for psychosis — including unnecessary treatment and stigma.8 Plus, this designation could cause 
considerable fear and distress for youth and their families. Consequently, the clinical high-risk criteria are not 
recommended for screening purposes, even though they remain useful for research.5
Next steps
Researchers have made considerable progress in evaluating interventions that aim to prevent psychosis, based 
on identifying high-risk youth. In the Review article that follows, we examine three such interventions.
overv iew
Youth receiving early 
mental health services 
may be less likely to 
need hospital care for 
psychosis.
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Can intervening 
early help at-risk 
youth?
It is well established that young people with psychosis have better outcomes when they receive effective treatment 
early in the course of the disorder.9 This 
knowledge has spurred efforts to try to 
prevent the onset of psychosis in at-risk 
young people. But how well are these 
efforts working? To answer this question, 
we conducted a systematic review of 
interventions designed to prevent psychosis 
in at-risk youth.
To identify the best available research 
evidence, we built quality assessment into 
our inclusion criteria. In particular, we 
required all studies to use randomized controlled trials (RCTs). We then searched for RCTs evaluating relevant 
interventions published between 2009 and 2020. (Please see the Methods section for more details on our 
search strategy and inclusion criteria.)
We retrieved and assessed 41 studies. Three RCTs evaluating three interventions met our inclusion criteria. 
The interventions were Omega-3 Polyunsaturated Fatty Acids (PUFAs),10–11 Auditory Cognitive Training12 
and Family-Focused Treatment.13 The sidebar provides information on two medication studies that failed to 
meet our inclusion criteria.
Diverse efforts to prevent psychosis
Participants in all three studies were assessed as being at high risk 
for psychosis based on the clinical high-risk threshold. But the 
interventions diverged considerably. The first study set out to 
determine whether PUFAs could prevent psychosis, based on reports 
that the supplement showed some evidence of beneficial effects for 
adults with schizophrenia.10 This double-blinded RCT randomly 
assigned participants to receive either PUFA or placebo capsules four 
times daily for three months. (Researchers did not receive any funding 
from the makers of this dietary supplement.) Both intervention 
and control youth also received case management services, including education and support.10 As well, all 
youth were offered nine counselling sessions to address symptoms, social relationships and family issues, plus 
crisis management sessions if needed. Case management and counselling were offered for 40 weeks and were 
accessed by youth in both groups at similar rates. However, youth were not permitted to use antipsychotics 
during the three-month trial period. Although the authors did not explain this restriction, they may have 
wanted to ensure that medications did not confound the outcomes.10
r e v i e w
Early effective treatments can lead to better outcomes for youth.
What about medications?
I
n our search for prevention interventions, we 
found randomized controlled trials evaluating 
the antipsychotic medications olanzapine and 
risperidone.
15–16
 However, both studies failed 
to meet inclusion criteria because they did 
not enroll enough youth to adequately test for 
differences between medications and placebos. 
Since medications may show promise for 
prevention of psychosis, it would be helpful to 
address this serious limitation in future trials.
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In contrast, Auditory Cognitive Training aimed to improve cognitive functioning for at-risk young 
people — given that deficits in memory, attention and verbal fluency can be common in this group.12 
Training involved computerized exercises designed to improve the speed and accuracy of auditory information 
processing, as well as improve working memory.14 Tasks included distinguishing between two similar sounds 
and carrying out verbal instructions from memory.14 Participants were randomly assigned to receive Auditory 
Cognitive Training or video games, the active control condition, for 40 hours over eight 
weeks. Youth in both groups could also receive treatments not provided through the study, 
including psychotherapy and medications.12
The third intervention, Family-Focused Treatment, aimed to reduce psychotic 
symptoms and improve overall functioning. This intervention focused on assisting parents 
to help youth engage and encouraged positive family interactions.13 Participating families 
were randomly assigned to either the intervention or a one-month family educational 
program. Family-Focused Treatment consisted of 18 family therapy sessions. These 
sessions included identifying stressors associated with psychotic symptoms and providing 
participants with ways of coping with them. They also encouraged positive family 
communications and worked on building problem-solving and conflict resolution skills. Both intervention 
and control families could also receive study-based crisis management sessions as needed. Study psychiatrists 
managed psychiatric medications, unless youth preferred to continue with their community practitioners. 
Study psychiatrists could start antipsychotic medications during the trial if needed.13 Table 1 gives more 
information about the three studies.
Even though 
prevention research 
is still emerging, 
practitioners can 
play a crucial role by 
providing services 
for youth at risk of 
psychosis.
rev iew
 
Table 1: Psychosis Prevention Studies
Ages* (years) 
(countries)
13–25  
(Austria)
12–30  
(United States)
12–32  
(United States + 
Canada)
Sample  
size
81
 
83
 
129
Approach
 
PUFA capsules 4 times daily over 3 months
 
40 hours of computerized training in auditory 
information processing over 2 months
18 hours of family therapy over 6 months      
Intervention
 
Omega-3 Polyunsaturated 
Fatty Acids (PUFAs)
10
Auditory Cognitive Training 
12
 
Family-Focused Treatment 
13
* Although these studies included individuals older than 18, the average age of participants was 18 or younger for all studies. 
Dietary supplement outcomes 
PUFA supplements led to substantial benefits for young people at long-term follow-up of nearly seven 
years, with a high retention rate (87.7% of participants). At this follow-up, 9.8% of intervention youth had 
developed a psychotic disorder, compared with 40.0% of controls.11 This benefit was found despite fewer 
intervention youth than controls being prescribed antipsychotic medications by follow-up (29.4% vs. 54.3%, 
respectively). As well, intervention youth reported fewer psychotic symptoms and better overall functioning 
than controls. They were also less likely to meet diagnostic criteria for other mental disorders, including mood, 
anxiety and substance use disorders (52.9% vs. 82.9%, respectively). How might PUFAs work? The study 
authors admitted uncertainty, but speculated that PUFAs may prevent brain changes that could contribute  
to psychosis.11
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Psychosocial intervention outcomes
Auditory Cognitive Training did not produce significant benefits.12 At the end of the intervention, there was 
no difference between the intervention and control groups regarding psychotic symptoms, overall functioning 
or any cognitive outcomes, including learning, memory, problem-solving and processing speed. These poor 
outcomes may be related to high attrition, as 42% of youth left the study before its completion.12 (The trial 
still met our inclusion criteria because the authors used a statistical technique to account for attrition.)
Family-Focused Treatment also failed to produce significant benefits.13 At the end of treatment, no 
statistically significant difference was found between intervention and control groups regarding psychotic 
symptoms or overall functioning. Poor attendance may have played a role in these poor outcomes; 
approximately 25% of families participated in less than half of the sessions.
Notably, both psychosocial intervention studies lacked long-term follow-up, which may have contributed 
to the poor findings. Only about 18% of youth who meet clinical high-risk criteria go on to develop psychotic 
disorders within six months of receiving the designation.7 So assessing outcomes only at the end of treatment 
was likely insufficient to identify long-term gains. Table 2 summarizes the outcomes for these three studies. 
rev iew
 
Table 2: Psychosis Prevention Study Outcomes
OutcomesFollow-upIntervention
 or  Statistically significant improvements for intervention over control participants.
  No statistically significant difference between treatment and control participants.
	Psychotic disorder diagnoses
	Psychotic symptoms
	Antipsychotic medication use
 Overall functioning
  Psychotic symptoms
  Overall functioning
  Learning, memory, problem-solving + processing speed
  Psychotic symptoms
  Overall functioning
6¾ years 
 
 
None 
 
None 
  
Omega-3 Polyunsaturated 
Fatty Acids (PUFAs) 
11
 
 
Auditory Cognitive Training 
12
Family-Focused Treatment 
13 
 
Implications for research, practice and policy
The results of these three studies suggest three recommendations to guide research, practice and policy.
•  Build on what has been discovered so far. Although the one RCT examining PUFA supplements 
had promising outcomes, more studies are needed because these results have yet to be replicated. More 
research is particularly important given that the other RCT evaluating PUFAs with high-risk individuals 
found no benefits in preventing psychosis.17 (This study did not meet our inclusion 
criteria because the average age of participants was 19.) Future studies could also 
make psychosocial interventions such as cognitive training and family therapy more 
appealing — with the goal that improved attendance might lead to better outcomes. 
Psychosocial studies could also ensure long-term follow-up.
•  Learn from effective adult interventions. Rigorous evidence from studies involving 
high-risk adults indicates that psychosocial interventions can prevent psychosis in this 
population. For example, one RCT found that cognitive training reduced the likelihood 
of developing psychosis.18 Another RCT found that an integrated psychological intervention, which 
included cognitive-behavioural therapy, skills training, cognitive training and family education, effectively 
Further research is 
needed, particularly 
on possible 
environmental  
causes of psychotic 
disorders.
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prevented psychosis in young adults.19 Evaluating these two interventions in high-risk youth could 
result in new — and earlier — prevention options. Policy-makers may want to consider supporting such 
evaluations. 
•  Provide comprehensive care for high-risk young people. Even though prevention research is still 
emerging, practitioners can play a crucial role by providing services for youth at risk of psychosis. Such 
services include monitoring, providing education and supports, and prescribing antipsychotics if these 
medications become warranted. 
Given that psychosis profoundly influences developmental trajectories starting in adolescence, and given 
the high associated burdens and costs for individuals and for society,3, 20 preventing psychosis is an important 
goal. Positive youth results for PUFA supplements and positive adult results for psychological interventions 
suggest that prevention may be achievable for some young people. Further research is needed, particularly  
on possible environmental causes of psychotic disorders. Such causes have the potential to guide new 
prevention interventions.3 Meanwhile, it is imperative to support youth at high risk for psychosis as well as 
their families.
rev iew
Ample support from family members enables youth to flourish.
Chi ldren ’s  Menta l  Heal th  Research Quar ter ly  Vol .  14 ,  No.  3    9    © 2020 Children’s Health Policy Centre, Simon Fraser University
We use systematic review methods adapted from the Cochrane Collaboration and Evidence-Based Mental Health. We build quality assessment into our inclusion criteria to ensure that we report on the best available research evidence — requiring that intervention studies use randomized 
controlled trials (RCTs) and meet additional quality indicators. For this review, we searched for RCTs on 
effective interventions for preventing psychosis. Table 3 outlines our database search strategy.
m e t h o d s
•	 CINAHL,	ERIC,	Medline	and	PsycINFO
•	 Schizophrenia	or	psychosis	and prevention, intervention or treatment
•	 Peer-reviewed	articles	published	in	English	between	2009	and	2020
•	 Pertaining	to	children	aged	18	years	or	younger
•	 RCT	methods	used
Sources
Search Terms
Limits
Table 3: Search Strategy
To identify additional RCTs, we also hand-searched the Web of Science database, reference lists from 
relevant published systematic reviews and previous issues of the Quarterly. Using this approach, we identified 
41 RCTs. Two team members then independently assessed each RCT, applying the inclusion criteria outlined 
in Table 4.
Three RCTs met all the inclusion criteria. Figure 1 depicts our search process, adapted from Preferred 
Reporting Items for Systematic Reviews and Meta-Analyses. Data from these studies were then extracted, 
summarized and verified by two or more team members. Throughout our process, any differences between 
team members were resolved by consensus.
Table 4: Inclusion Criteria for RCTs 
•	 Participants	were	randomly	assigned	at	study	outset	to	intervention	and	comparison	groups	 
(i.e., no intervention or minimal intervention) 
•	 Participants	had	mean	age	of	18	years	or	younger
•	 Studies	provided	clear	descriptions	of	participant	characteristics,	settings	and	interventions
•	 Interventions	were	evaluated	in	settings	that	were	applicable	to	Canadian	policy	and	practice
•	 Interventions	aimed	to	prevent	psychosis
•	 At	study	outset,	most	participants	did	not	meet	diagnostic	criteria	for	a	psychotic	disorder
•	 Attrition	rates	were	20%	or	less	at	final	assessment	and/or	intention-to-treat	analysis	was	used
•	 Youth	outcome	indicators	included	psychotic	symptom	and/or	diagnostic	outcomes
•	 Studies	reported	levels	of	statistical	significance	for	primary	outcome	measures
•	 Psychosocial	studies	had	at	least	one	outcome	rater	blinded	to	participants’	group	assignment
•	 Medication	and	supplement	studies	used	double-blinding	procedures	and	placebo	controls
•	 Studies	were	excluded	when	there	was	insufficient	statistical	power	or	inappropriate	analyses*
*	 We	defined	inappropriate	analyses	as	those	that	did	not	control	for	multiple	comparisons	and/or	variables	that	
    might influence the outcome of interest. 
For more information on our research methods, please contact
Jen Barican, chpc_quarterly@sfu.ca 
Children’s Health Policy Centre, Faculty of Health Sciences  
Simon Fraser University, Room 2435, 515 West Hastings St. Vancouver, BC  V6B 5K3 
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Records identified through  
database searching
(n = 1,173)
Records identified through 
hand-searching
(n = 15)
Records excluded after
title screening
(n = 610)
Abstracts excluded
(n = 503)
Full-text articles excluded
(n = 38 studies
[58 articles])
Total records screened (n = 1,188)
Abstracts screened for relevance
(n = 578)
Full-text articles assessed
for eligibility
(n = 41 studies [75 articles])
Studies included in review
(n = 3 RCTs [17 articles])
Figure 1: Search Process for RCTs
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Practitioners and policy-makers need good evidence about whether a given intervention works to help children. Randomized controlled trials (RCTs) are the gold standard for assessing whether an intervention is effective. In RCTs, children, youth or families are randomly assigned to the intervention 
group or to a comparison or control group. By randomizing participants — that is, by giving every young 
person an equal likelihood of being assigned to a given group — researchers can help ensure the only 
difference between the groups is the intervention. This process provides confidence that benefits are due to the 
intervention rather than to chance or other factors. As well, the RCT assessing PUFAs was double-blinded so 
neither youth nor researchers knew who was in the intervention and control groups. This approach is typical 
for dietary supplement and medication studies. It helps to ensure that beliefs about the potential effectiveness 
of the intervention do not influence outcomes.
Then, to determine whether the intervention actually provides benefits, researchers analyze relevant 
outcomes. If an outcome is found to be statistically significant, it helps provide certainty the intervention 
was effective rather than results appearing that way due to chance. In the studies we reviewed, researchers  
set a value enabling at least 95% confidence that the observed results actually reflected the program’s real 
impact.  
When researchers and youth are unaware of who is receiving the intervention, it helps to ensure that beliefs about 
effectiveness do not influence outcomes.
r e s e a r c h t e r m s e x p l a i n e d
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BC government staff can access original articles from BC’s Health and Human Services Library. Articles 
marked with an asterisk (*) include randomized controlled trial data that was featured in our Review article.
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